Literature DB >> 17482310

Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering.

Hyun Jung Chung1, Tae Gwan Park.   

Abstract

A wide range of polymeric scaffolds have been intensively studied for use as implantable and temporal devices in tissue engineering. Biodegradable and biocompatible scaffolds having a highly open porous structure and good mechanical strength are needed to provide an optimal microenvironment for cell proliferation, migration, and differentiation, and guidance for cellular in-growth from host tissue. A variety of natural and synthetic polymeric scaffolds can be fabricated in the form of a solid foam, nanofibrous matrix, microsphere, or hydrogel. Biodegradable porous scaffolds can be surface engineered to provide an extracellular matrix mimicking environment for better cell adhesion and tissue in-growth. Furthermore, scaffolds can be designed to release bioactive molecules, such as growth factors, DNA, or drugs, in a sustained manner to facilitate tissue regeneration. This paper reviews the current status of surface engineered and drug releasing scaffolds for tissue engineering.

Mesh:

Substances:

Year:  2007        PMID: 17482310     DOI: 10.1016/j.addr.2007.03.015

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  57 in total

Review 1.  A biomaterials approach to peripheral nerve regeneration: bridging the peripheral nerve gap and enhancing functional recovery.

Authors:  W Daly; L Yao; D Zeugolis; A Windebank; A Pandit
Journal:  J R Soc Interface       Date:  2011-11-16       Impact factor: 4.118

Review 2.  Evaluation of corneal cell growth on tissue engineering materials as artificial cornea scaffolds.

Authors:  Hai-Yan Wang; Rui-Hua Wei; Shao-Zhen Zhao
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

3.  3D printed PLA-based scaffolds: a versatile tool in regenerative medicine.

Authors:  Tiziano Serra; Miguel A Mateos-Timoneda; Josep A Planell; Melba Navarro
Journal:  Organogenesis       Date:  2013-08-19       Impact factor: 2.500

4.  Microfabrication of an asymmetric, multi-layered microdevice for controlled release of orally delivered therapeutics.

Authors:  Kristy M Ainslie; Casey M Kraning; Tejal A Desai
Journal:  Lab Chip       Date:  2008-05-16       Impact factor: 6.799

5.  Fabricating scaffolds by microfluidics.

Authors:  Kuo-Yuan Chung; Narayan Chandra Mishra; Chen-Chi Wang; Feng-Hui Lin; Keng-Hui Lin
Journal:  Biomicrofluidics       Date:  2009-04-21       Impact factor: 2.800

Review 6.  Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds.

Authors:  Viviana Mouriño; Aldo R Boccaccini
Journal:  J R Soc Interface       Date:  2009-10-28       Impact factor: 4.118

7.  Incorporating platelet-rich plasma into electrospun scaffolds for tissue engineering applications.

Authors:  Scott A Sell; Patricia S Wolfe; Jeffery J Ericksen; David G Simpson; Gary L Bowlin
Journal:  Tissue Eng Part A       Date:  2011-09-09       Impact factor: 3.845

8.  Comparison of TGFbR2 down-regulation in expanded HSCs on MBA/DBM scaffolds coated by UCB stromal cells.

Authors:  Zahra Sadat Hashemi; Mehdi Forouzandeh Moghadam; Masoud Soleimani
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-12-25       Impact factor: 2.416

Review 9.  Supramolecular biofunctional materials.

Authors:  Jie Zhou; Jie Li; Xuewen Du; Bing Xu
Journal:  Biomaterials       Date:  2017-03-12       Impact factor: 12.479

Review 10.  Progress of key strategies in development of electrospun scaffolds: bone tissue.

Authors:  Sumit Pramanik; Belinda Pingguan-Murphy; Noor Azuan Abu Osman
Journal:  Sci Technol Adv Mater       Date:  2012-08-08       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.